Spinal Muscular Atrophy (SMA) Archives

Spinal Muscular Atrophy (SMA) predominantly impacts infants and children, causing difficulties in muscle usage. This condition leads to the breakdown of nerve cells in the brain and spinal cord, disrupting the transmission of messages controlling muscle movement from the brain.

As a result, affected children experience muscle weakness and atrophy, facing challenges in controlling head movement, sitting without assistance, and even walking. In severe cases, they may encounter difficulties in swallowing and breathing as the disease progresses.

SMA encompasses various types, each differing in severity. While there is currently no cure, treatments can alleviate certain symptoms and, in some instances, prolong life expectancy. Ongoing research aims to discover novel approaches to combat the disease.

It’s important to note that every individual with SMA will have a unique experience. Regardless of the extent of movement limitations, the condition does not impact intelligence. Affected individuals can still form friendships and engage in social activities.

Causes of Spinal Muscular Atrophy

Spinal Muscular Atrophy (SMA) is a genetic disorder inherited from parents. If a child has SMA, it means they have inherited two copies of a defective gene, one from each parent.

This genetic mutation results in the body’s inability to produce a specific type of protein crucial for the survival of cells controlling muscle movement. Without this protein, these cells eventually deteriorate.

If a child inherits a faulty gene from only one parent, they won’t develop SMA but will become carriers of the disease. As carriers, they can pass on the defective gene to their offspring in the future.

Symptoms of Spinal Muscular Atrophy

Spinal Muscular Atrophy (SMA) presents a range of symptoms, which vary depending on the type of SMA:

Type 0: This is the rarest and most severe form, developing during pregnancy. Babies with Type 0 SMA exhibit reduced movement in the womb, along with joint problems, weak muscle tone, and breathing difficulties. Sadly, many infants with this type do not survive due to severe respiratory issues.
Type 1: Also severe, Type 1 SMA manifests early in infancy. Children with Type 1 struggle to support their head or sit unaided. They often have floppy limbs and difficulties with swallowing. Respiratory muscle weakness is a major concern, with most children not surviving beyond the age of 2 due to breathing complications.
Type 2: Occurring in children aged 6-18 months, Type 2 SMA ranges from moderate to severe. Symptoms primarily affect the legs, though arm involvement is possible. Children may achieve sitting and standing with assistance. Type 2 is also referred to as chronic infantile SMA.
Type 3: Symptoms typically emerge between 2 to 17 years of age, representing the mildest form of the disease. Children with Type 3 SMA can often stand or walk independently but may encounter difficulties with activities such as running, climbing stairs, or rising from a chair. Later in life, they may require a wheelchair for mobility. Also known as Kugelberg-Welander disease or juvenile SMA.
Type 4: This form of SMA manifests in adulthood, with symptoms such as muscle weakness, twitching, and breathing issues. Typically, only the upper limbs and legs are affected. Despite having symptoms throughout life, individuals with Type 4 SMA can maintain mobility and may even improve with targeted exercises guided by a physical therapist.

It’s essential to recognize that there is considerable variability in how SMA affects individuals. Many people with SMA can continue working for extended periods. Support from medical professionals, peers with similar conditions, and loved ones can provide valuable emotional assistance during the journey with this disease.

Diagnosis of Spinal Muscular Atrophy

Diagnosing SMA can be challenging because its symptoms may resemble those of other conditions. To aid in diagnosis, doctors may inquire about developmental milestones, such as head control or rolling over, any difficulties in sitting or standing independently, and observations of breathing issues. They may also ask about any family history of similar symptoms.

Several tests can help confirm a diagnosis:

Genetic Testing: This involves analyzing a blood sample from the child to identify missing or defective genes associated with SMA.
Creatine Kinase (CK) Blood Test: Elevated levels of CK in the blood indicate possible muscle damage, which is common in SMA.
Nerve Tests: Electromyogram (EMG) assesses nerve function by sending electrical impulses through nerves to observe muscle response.
Imaging Tests: Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) scans provide detailed images of the body’s internal structures, aiding in identifying any abnormalities.
Muscle Tissue Biopsy: This involves removing muscle cells either through a needle or a small incision to examine them under a microscope for abnormalities.

These tests not only help diagnose SMA but also rule out other conditions with similar symptoms, ensuring an accurate diagnosis and appropriate management plan.

SMA Treatments

Treatment options for Spinal Muscular Atrophy (SMA) have significantly advanced with the approval of several medications by the FDA, along with supportive therapies. Here’s a breakdown of treatment options:

Medications:
- Nusinersen (Spinraza): This medication modifies the SMN2 gene to increase protein production. Administered via injection into the fluid surrounding the spinal cord, it requires regular doses every few months. Studies indicate improvement in strength and disease progression in approximately 40% of individuals.
- Onasemnogene abeparvovec-xioi (Zolgensma): This gene therapy replaces the faulty SMN1 gene, typically administered as a one-time infusion directly into a vein. It has been shown to accelerate developmental milestones in infants under 2 years old.
- Risdiplam (Evrysdi): This oral medication helps prevent SMN2 gene disruption, allowing proper protein production. Daily doses based on weight have demonstrated improved muscle function in clinical trials.
Supportive Therapies:
- Breathing Support: Weak respiratory muscles, especially in Types 1 and 2 SMA, may require breathing aids such as special masks, mouthpieces, or machines to assist with breathing.
- Nutrition Management: Weakness in mouth and throat muscles can lead to feeding difficulties. Nutritionists may be involved, and some infants may require feeding tubes to ensure adequate nutrition and growth.
- Physical and Occupational Therapy: These therapies focus on exercises and activities to maintain joint health and muscle strength. Assistive devices like leg braces, walkers, or electric wheelchairs may be recommended.
- Assistive Devices: Special tools can aid in daily activities like using computers, phones, writing, and drawing, enhancing independence.
- Spinal Care: Children with SMA may develop spinal curvature, necessitating the use of back braces during growth phases or surgical intervention once growth is complete to correct spinal deformities.

These treatment approaches, combined with comprehensive medical care and support, aim to improve quality of life, manage symptoms, and slow disease progression for individuals living with SMA. Regular communication with healthcare providers and adherence to treatment plans are essential for optimal outcomes.

Spinal Muscular Atrophy Childcare

Caring for a child with Spinal Muscular Atrophy (SMA) involves various aspects of daily life, and as a family, there are numerous ways to support and assist your child. A multidisciplinary team comprising doctors, therapists, and support groups can provide invaluable assistance in managing your child’s care while ensuring they can participate in family activities and maintain friendships.

Your child may require ongoing care from different specialists, including:

Pulmonologists: Experts in lung health who can address respiratory concerns commonly associated with SMA.
Neurologists: Specialized in nerve-related conditions, neurologists play a key role in managing SMA and addressing neurological issues.
Orthopedists: These doctors focus on bone health and can help manage orthopedic problems that may arise due to SMA.
Gastroenterologists: Specialists in digestive health who can assist with managing any stomach disorders your child may experience.
Nutritionists: These professionals can guide on optimizing your child’s diet to support their overall health and well-being.
Physical Therapists: Trained in using exercise and movement techniques to improve mobility, physical therapists are crucial in helping your child maintain and enhance their range of motion.

This collaborative team can assist you in making informed decisions about your child’s healthcare needs, ensuring they receive comprehensive care tailored to their specific requirements. It’s important to avoid feeling overwhelmed by the responsibilities of caregiving, and seeking support from relevant support groups can provide you with valuable opportunities to connect with others who are experiencing similar challenges.

Outlook

The outlook for individuals with Spinal Muscular Atrophy (SMA) varies depending on the timing and severity of symptoms. In severe cases, such as Type 1 SMA, symptoms may manifest from birth to around 6 months of age. Most babies with Type 1 typically exhibit signs of the disease by around 3 months of age, experiencing delayed development and difficulties with activities like sitting up or crawling. While life expectancy for children with Type 1 SMA is often limited, with proper medical care and support from healthcare professionals and a support team, their quality of life can be enhanced, making their time as comfortable as possible.

For individuals with other types of SMA, medical interventions and supportive care can alleviate symptoms and improve quality of life over many years and even throughout their lifetime. Each person’s experience with SMA is unique, and developing a personalized treatment plan can significantly enhance their quality of life.

Several organizations provide valuable support and resources for individuals and families affected by SMA:

Cure SMA: This organization focuses on funding research for treating and curing SMA. Their SMArt Moves initiative emphasizes the importance of early diagnosis and treatment. Cure SMA also offers support through local chapters and their website, providing information and assistance to those newly diagnosed.
Muscular Dystrophy Association (MDA): MDA provides information, links to services, and support groups in local communities.
SMA Foundation: Dedicated to accelerating the search for SMA treatments, this foundation collaborates with researchers, develops clinical trials, and raises awareness about this genetic condition.

These organizations offer valuable support, information, and connections to resources that can help individuals and families navigate the challenges of living with SMA.

Sources

Genetics Home Reference: “Spinal muscular atrophy,” “SMN1 gene,” “SMN2 gene.”
KidsHealth: “Spinal Muscular Atrophy (SMA).”
Columbia University Department of Neurology: “Q&A on Spinraza Treatment for Spinal Muscular Atrophy (SMA) Patients.”
FDA: “FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortality,” “FDA approves first drug for spinal muscular atrophy.”
Muscular Dystrophy Association: “Spinal Muscular Atrophy.”
Medscape: “Spinal Muscular Atrophy.”
New England Journal of Medicine: “Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.”
Muscular Dystrophy UK: “Developing a genetic therapy for spinal muscular atrophy.”
Science Advances: “Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model.”
National Institute of Neurological Disorders and Stroke: “NINDS Spinal Muscular Atrophy Information.”
Boston Children’s Hospital: “Spinal Muscular Atrophy (SMA).”
Jennifer Trust for Spinal Muscular Therapy: “Adult Onset SMA.”
Cure SMA: “Therapeutic Approaches.”